Challenges in the Design of Clinically Useful Brain-targeted Drug Nanocarriers

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|21|37|4227-4246

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.21, Iss.37, 2014-12, pp. : 4227-4246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Brain-Targeted Drug Delivery: Experiences to Date

By Bodor N.   Buchwald P.  

American Journal of Drug Delivery, Vol. 1, Iss. 1, 2003-01 ,pp. : 13-26

Adis International

Access to resources Recommend Favorite

Brain-targeted drug delivery for Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Apoptosis: a clinically useful measure of antiretroviral drug toxicity?

By Hooker David James   Cherry Catherine Louise  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 12, 2009-12 ,pp. : 1543-1553

Informa Healthcare

Access to resources Recommend Favorite

Saccharide Modified Pharmaceutical Nanocarriers for Targeted Drug and Gene Delivery

By  

Current Pharmaceutical Design, Vol. 15, Iss. 32, 2009-11 ,pp. : 3826-3836

Bentham Science Publishers

Access to resources Recommend Favorite

Active Targeted Drug Delivery for Microbes Using Nano-Carriers

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 15, 2015-08 ,pp. : 1525-1531

Bentham Science Publishers

Access to resources Recommend Favorite